Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
05 Dec 2023
05 Dec 2023
Historique:
received:
06
05
2023
accepted:
23
11
2023
medline:
7
12
2023
pubmed:
6
12
2023
entrez:
5
12
2023
Statut:
epublish
Résumé
As key mediators of cellular communication, extracellular vesicles (EVs) have been actively explored for diagnostic and therapeutic applications. However, effective methods to functionalize EVs and modulate the interaction between EVs and recipient cells are still lacking. Here we report a facile and universal metabolic tagging technology that can install unique chemical tags (e.g., azido groups) onto EVs. The surface chemical tags enable conjugation of molecules via efficient click chemistry, for the tracking and targeted modulation of EVs. In the context of tumor EV vaccines, we show that the conjugation of toll-like receptor 9 agonists onto EVs enables timely activation of dendritic cells and generation of superior antitumor CD8
Identifiants
pubmed: 38052869
doi: 10.1038/s41467-023-43914-8
pii: 10.1038/s41467-023-43914-8
pmc: PMC10697976
doi:
Substances chimiques
Cancer Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8047Subventions
Organisme : NCI NIH HHS
ID : R21 CA270872
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA234025
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA274738
Pays : United States
Organisme : NIBIB NIH HHS
ID : T32 EB019944
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
Nat Commun. 2018 Jul 9;9(1):2658
pubmed: 29985392
Science. 2005 Jul 22;309(5734):581-5
pubmed: 15961631
Nat Commun. 2020 Apr 14;11(1):1790
pubmed: 32286296
Immunol Lett. 2021 Nov;239:32-41
pubmed: 34418488
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Sep;14(5):e1824
pubmed: 35708013
Biomaterials. 2019 Oct;218:119305
pubmed: 31323538
FASEB J. 2009 May;23(5):1541-57
pubmed: 19109410
Nat Chem. 2020 Dec;12(12):1102-1114
pubmed: 33219365
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16793-7
pubmed: 17942682
N Engl J Med. 2010 Jul 29;363(5):411-22
pubmed: 20818862
Chem Rev. 2015 Oct 14;115(19):11109-46
pubmed: 26154342
Biomed Pharmacother. 2022 Nov;155:113690
pubmed: 36099793
Expert Rev Vaccines. 2015 Mar;14(3):447-59
pubmed: 25308798
Cancers (Basel). 2023 May 19;15(10):
pubmed: 37345176
Cell Commun Signal. 2022 Sep 19;20(1):145
pubmed: 36123730
Angew Chem Int Ed Engl. 2016 Apr 25;55(18):5452-6
pubmed: 27010510
Methods Enzymol. 2006;415:230-50
pubmed: 17116478
Bioconjug Chem. 2014 Oct 15;25(10):1777-84
pubmed: 25220352
Biomaterials. 2021 Aug;275:120964
pubmed: 34147721
Nat Protoc. 2007;2(11):2930-44
pubmed: 18007630
Cancer Res. 1990 Mar 1;50(5):1550-8
pubmed: 1689212
Nat Med. 2004 Sep;10(9):909-15
pubmed: 15340416
Biomaterials. 2016 Dec;111:55-65
pubmed: 27723556
Biotechnol J. 2020 Jan;15(1):e1900163
pubmed: 31595685
Front Immunol. 2021 Jul 14;12:711565
pubmed: 34335627
Immunol Lett. 2018 Jul;199:36-43
pubmed: 29800589
STAR Protoc. 2022 Sep 16;3(3):101664
pubmed: 36097382
J Control Release. 2015 Dec 10;219:278-294
pubmed: 26143224
J Drug Target. 2020 Feb;28(2):129-141
pubmed: 31280623
Nat Commun. 2020 Nov 10;11(1):5696
pubmed: 33173046
Science. 2008 May 2;320(5876):664-7
pubmed: 18451302
Nat Mater. 2018 Sep;17(9):761-772
pubmed: 30104668
Blood. 2004 Nov 15;104(10):3257-66
pubmed: 15284116
Methods Enzymol. 2020;631:239-255
pubmed: 31948550
Science. 2004 Mar 5;303(5663):1526-9
pubmed: 14976262
J Control Release. 2021 Feb 10;330:101-110
pubmed: 33333118
Nat Rev Drug Discov. 2011 Aug 01;10(8):591-600
pubmed: 21804596
Nature. 2004 Aug 19;430(7002):873-7
pubmed: 15318217
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):1821-6
pubmed: 20080615
Nat Chem Biol. 2017 Apr;13(4):415-424
pubmed: 28192414
Cancer Res. 1982 Nov;42(11):4394-8
pubmed: 6290036
Sci Rep. 2017 May 12;7(1):1878
pubmed: 28500324
J Immunol. 2007 Jun 1;178(11):6867-75
pubmed: 17513735
Adv Clin Chem. 2016;74:103-41
pubmed: 27117662
J Clin Invest. 2016 Apr 1;126(4):1208-15
pubmed: 27035812
Expert Rev Vaccines. 2011 Apr;10(4):499-511
pubmed: 21506647
Nat Rev Immunol. 2020 May;20(5):321-334
pubmed: 32005979
Cancer Lett. 2017 Dec 28;411:182-190
pubmed: 28947140
Proc Natl Acad Sci U S A. 1978 Jul;75(7):3317-21
pubmed: 356052
J Biol Chem. 1975 Jun 10;250(11):4297-304
pubmed: 1126952
J Immunol. 2008 Mar 1;180(5):3081-90
pubmed: 18292531
Nat Mater. 2020 Nov;19(11):1244-1252
pubmed: 32424368
J Vis Exp. 2010 Oct 12;(44):
pubmed: 20972413
Mol Ther. 2008 Apr;16(4):782-90
pubmed: 18362931